[4] Sabulski A, Myers KC, Bleesing JJ, et al. Graft rejection markers in children undergoing hematopoietic cell transplant for bone marrow failure. Blood Adv. 2021;5(22):4594-4604. doi:10.1182/bloodadvances.2021005231 ...
[8]Song Y,Yin Q,Wang J,et al.Autologous Hematopoietic Stem Cell Transplantation for Patients with Lymphoma-Associated Hemophagocytic lymphohistiocytosis[J].Cell Transplant,2021,30:83852363. 审批号:NP-24813 审批日期:2022年11月 *此文仅用于向...
In contrast, we examined retrospective data for 19 cases of late-onset P-HLH with available treatment data and compared the results of conservative medical therapy with hematopoietic stem cell transplant (HSCT) postremission therapy. Our patient displayed compound heterozygous mutations in PRF1 that ...
Strongyloides stercoralis infection in allogeneic stem cell transplant: a case report and review of the literature. Strongyloides stercoralis infections may be documented in low-endemicity areas, particularly in immigrants from endemic areas. The case of a patient from B... Iori, A.P.,A Ferretti...
These are etoposide-based regimens containing corticosteroids, cyclosporine A, intravenous immunoglobulins (IVIG), intrathecal therapy, and liberal use of allogeneic stem cell transplant in higher risk patients [23]. How well these treatment protocols apply to adults is poorly understood. Table 2. ...
In December 2022, the patient underwent allogenic hematopoietic stem cell transplantation (allo-HSCT). The allogeneic hematopoietic stem cell transplant (HSCT) was sourced from an HLA-identical unrelated donor (5.5 × 106 CD34+ cells). The conditioning regimen comprised thiotepa, treosulfan, and anti...
5 Although it is generally accepted that relapsed/refractory EBV-HLH will ultimately require allogeneic hematopoietic stem cell transplant (HSCT) to achieve a cure, the authors sought to explore whether restoration of immune function through PD-1 inhibition could lead to long-standing control of EBV...
Early stem cell transplant in genetic disease has also been shown to halt CNS disease and prevent further sequelae.doi:10.1007/978-3-319-59632-7_10AnnaCarin HorneKarin Beutel
Case A 25-year-old woman with Hodgkin lymphoma, refractory to multiple chemotherapies, autologous transplant and Nivolumab, who underwent haploidentical HSCT, was admitted on day +33 with persistent high-grade fevers. Blood counts were unremarkable, except for eosinophilia. She received broad spectrum...
Salvage chemotherapy and autologous hematopoietic stem cell transplant (HSCT) resulted in remission. Two years later, he presented with an acute febrile illness with facial and proximal myoclonus, dysmetria, dysarthria, and ataxia. He was pancytopenic without hepatosplenomegaly or lymphadenopathy. Flow ...